Intestinal Diseases  >>  GSK1399686  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GSK1399686 / GSK
NCT00721812: A First Time In Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1399686

Completed
1
87
Europe
GSK1399686
GlaxoSmithKline
Inflammatory Bowel Diseases
05/09
05/09

Download Options